InMed Pharmaceuticals (INM) Insider Trading & Ownership $2.56 -0.11 (-3.93%) As of 12:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock InMed Pharmaceuticals (NASDAQ:INM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.43%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$29.60KNumber OfInsiders Selling(Last 3 Years)0 Get INM Insider Trade Alerts Want to know when executives and insiders are buying or selling InMed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INM Insider Buying and Selling by Quarter InMed Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/21/2024Andrew HullDirectorBuy1,875$7.80$14,625.00 2/20/2024Eric A AdamsCEOBuy2,080$7.20$14,976.00 (Data available from 1/1/2013 forward) INM Insider Trading Activity - Frequently Asked Questions Who is on InMed Pharmaceuticals' Insider Roster? The list of insiders at InMed Pharmaceuticals includes Andrew Hull, and Eric A Adams. Learn more on insiders at INM. What percentage of InMed Pharmaceuticals stock is owned by insiders? 1.43% of InMed Pharmaceuticals stock is owned by insiders. Learn more on INM's insider holdings. Which InMed Pharmaceuticals insiders have been buying company stock? The following insiders have purchased INM shares in the last 24 months: Andrew Hull ($14,625.00), and Eric A Adams ($14,976.00). How much insider buying is happening at InMed Pharmaceuticals? Insiders have purchased a total of 3,955 INM shares in the last 24 months for a total of $29,601.00 bought. InMed Pharmaceuticals Key ExecutivesMr. Eric A. Adams B.S. Chem. (Age 61)M.I.B., President, CEO & Director Compensation: $347.82kMr. Michael Woudenberg P.Eng. (Age 55)Chief Operating Officer Compensation: $287.54kMs. Alexandra Diane-Janet Mancini M.Sc. (Age 71)Senior Vice President of Clinical & Regulatory Affairs Compensation: $279.39kDr. Sazzad Hossain M.Sc. (Age 66)Ph.D., Co-Founder Compensation: $137.33kMs. N. Netta Jagpal (Age 51)CFO & Corporate Secretary Ms. Sarah Li CPACGA, VP of Accounting & ControllerColin ClancySenior Director of Investor RelationsMr. Jerry P. GriffinVice President of Sales & MarketingDr. Eric Chih-Hsien Hsu (Age 54)Senior Vice President of Preclinical Research & Development Compensation: $253.46kDr. Shane A. Johnson Ph.D.Senior VP & GM of BayMedica More Insider Trading Tools from MarketBeat Related Companies CMMB Insider Trades AYTU Insider Trades CYCC Insider Trades BCAB Insider Trades SYBX Insider Trades FNCH Insider Trades SONN Insider Trades MRKR Insider Trades RVPH Insider Trades RLMD Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:INM) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredDrone Company Secures Major Defense Contract Amid Sweeping Policy ShiftOn July 10th, the White House and DoD announced a sweeping new directive to fast-track U.S. drone dominance. ...The Tomorrow Investor | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredOne stock to replace Nvidia"I said 'SELL' before this stock dropped 90%. Today, I'm shouting 'BUY NOW' before it's too late." In 2000,...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
